研究论文

乙酸酐促进的[3+3]环化反应合成2-喹啉酮衍生物

  • 赵瑜 ,
  • 陈卓 ,
  • 陈雪冰
展开
  • 1 红河学院理学院 云南蒙自 661199
* Corresponding author. E-mail:

收稿日期: 2020-07-30

  修回日期: 2020-08-25

  网络出版日期: 2020-09-22

基金资助

云南省科技厅项目(2017FD156); 云南省高校科技创新团队资助项目.

Synthesis of 2-Quinolinone Derivatives via [3+3] Cyclization Promoted by Acetic Anhydride

  • Yu Zhao ,
  • Zhuo Chen ,
  • Xuebing Chen
Expand
  • 1 School of Science, Honghe University, Mengzi, Yunnan 661199

Received date: 2020-07-30

  Revised date: 2020-08-25

  Online published: 2020-09-22

Supported by

the Applied Basic Research Project of Yunnan(2017FD156); the Program for Innovative Research Team Technology) in University of Yunnan Province

摘要

2-喹啉酮结构单元广泛存在于天然产物和药物活性分子中, 并且是重要的杂环合成砌块. 建立了一种乙酸酐促进下, 环状β-烯胺酮和丙二酸通过[3+3]环合反应构建2-喹啉酮化合物的新方法, 产率为70%~87%. 该方法具有原料简单易得、操作简便、路线简洁、目标化合物可修饰性强等优点.

本文引用格式

赵瑜 , 陈卓 , 陈雪冰 . 乙酸酐促进的[3+3]环化反应合成2-喹啉酮衍生物[J]. 有机化学, 2021 , 41(2) : 731 -737 . DOI: 10.6023/cjoc202007070

Abstract

2-Quinolinone unit is frequently found in both natural products and pharmaceuticals. Furthermore, they are important heterocycle building blocks. Herein, a novel approach to the synthesis of 2-quinolinone derivatives has been established from [3+3] cyclization of β-enaminones with malonic acid promoted by acetic anhydride with yields of 70%~87%. The reaction is particularly attractive due to following advantages: simple starting materials, operational simplicity, concise synthetic route, easy purification, highly modifiability of target molecules and so on.

参考文献

[1]
(a) Cho J-Y.; Bae, S.-H.; Kim, H.-K.; Lee, M.-Y.; Choi, Y.-S.; Jin, B.-R.; Lee, H.-J.; Jeong, H.-Y.; Lee, Y.-G.; Moon, J.-K. J. Agric. Food Chem. 2015, 63, 3587.
[1]
(b) He J.; Lion U.; Sattler S.; Gollmick F.A.; Grabley S.; Cai J.; Meiners M.; Schünke H.; Schaumann K.; Dechert U.; Krohn M. J. Nat. Prod. 2005, 68, 1397.
[1]
(c) Freeman G.A.; Andrews III C.W.; Hopkins A.L.; Lowell G.S.; Schaller L.T.; Cowan J.R.; Gonzales S.S.; Koszalka G.W.; Hazen R.J.; Boone L.R.; Ferris R.G.; Creech K.L.; Roberts G.B.; Short S.A.; Weaver K.; Reynolds D.J.; Milton J.; Ren J.; Stuart D.I.; Stammers D.K.; Chan J.H. J. Med. Chem. 2004, 47, 5923.
[1]
(d) Godard A.; Fourquez J.M.; Tamion R.; Marsais F.; Quéguiner G. Synlett 1994, 235.
[1]
(e) Goossen L.J.; Deng G.; Levy L.M. Science 2006, 313, 662.
[1]
(f) Nakatsu T.; Johns T.; Kubo I.; Milton K.; Sakai M.; Chatani K.; Saito K.; Yamagiwa Y.; Kamikawa K. J. Nat. Prod. 1990, 53, 1508.
[2]
(a) Arya K.; Agarwal M. Bioorg. Med. Chem. Lett. 2007, 17, 86.
[2]
(b) Chen Y.-F.; Lin Y.-C.; Huang P.-K.; Chan H.-C.; Kuo S.-C.; Lee K.-H.; Huang L.-J. Bioorg. Med. Chem. Lett. 2013, 21, 5064.
[3]
Tedesco D.; Shaw A.N.; Bambal R.; Chai D.; Concha N.O.; Darcy M.G.; Dhanak D.; Fitch D.M.; Gates A.; Gerhardt W.G.; Halegoua D.L.; Han C.; Hofmann G.A.; Johnston V.K.; Kaura A.C.; Liu N.; Keenan R.M.; Lin-Goerke J.; Sarisky R.T.; Wiggall K.J.; Zimmerman M.N.; Duffy K.J. J. Med. Chem. 2006, 49, 3, 971.
[4]
Han S.; Zhang F.-F.; Qian H.-Y.; Chen L.-L.; Pu J.-B.; Xie X.; Chen J.-Z. J. Med. Chem. 2015, 58, 5751.
[5]
(a) Mizutani N.; Aoki Y.; Nabe T.; Ishiwara M.; Yoshino S.; Takagaki H.; Kohno S. Eur. J. Pharmacol. 2009, 602, 138.
[5]
(b) Ishiwara M.; Aoki Y.; Takagaki H.; Ui, Michio.; Okajima F.J. Pharmacol. Exp. Ther. 2003, 307, 583.
[6]
(a) Kulagowski J.J.; Baker R.; Curtis N.R.; Mawer I.M.; Moseley A.M.; Ridgill M.P.; Rowley M.; Stansfield I.; Leeson P.D. J. Med. Chem. 1994, 37, 1402.
[6]
(b) Uchida S.; Hiraoka S.; Namiki N. Chem. Pharm. Bull. 2015, 63, 354.
[7]
(a) Zhou T.; Wang D.; Qian J.; Zhao W. Chin. J. Org. Chem. 2017, 37, 1548. (in Chinese)
[7]
周婷, 王道林, 钱建华, 赵伟, 有机化学, 2017, 37, 1548.).
[7]
(b) Zhao Q.; Yao C.; Wang X. Chin. J. Org. Chem. 2016, 36, 1932. (in Chinese)
[7]
赵群, 姚昌盛, 王香善, 有机化学, 2016, 36, 1932.).
[7]
(c) Glasnov T.N.; Stadlbauer W.; Kappe C.O. J. Org. Chem. 2005, 70, 3864.
[7]
(d) Klásek A.; K?emen F.; K?emenová H.; Ly?ka A.; Rouchal M. Tetrahedron 2017, 73, 1583.
[7]
(e) Chilin A.; Marzano C.; Baccichetti F.; Simonato M.; Guiotto A. Bioorg. Med. Chem. Lett. 2003, 11, 1311.
[8]
(a) Manikandan R.; Jeganmohan M. Org. Lett. 2014, 16, 3568.
[8]
(b) Zhang X.; Liu H.; Jia Y.-A. Chem. Commun. 2016, 52, 7665.
[8]
(c) Wu J.-L.; Xiang S.-H.; Zeng J.; Leow M.; Liu X.-W. Org. Lett. 2015, 17, 222.
[9]
Zhong S.-S.; Huang P.; Wang X.-Y.; Lin M.; Ge C.-H. Chin. J. Org. Chem. 2018, 38, 1199. (in Chinese)
[9]
仲帅帅, 黄鹏, 王兴越, 林觅, 葛春华, 有机化学, 2018, 38, 1199.).
[10]
(a) Chen X.; Cui X.; Wu Y. Org. Lett. 2016, 18, 2411.
[10]
(b) Ikbal M.; Banerjee R.; Atta S.; Jana A.; Dhara D.; Anoop A.; Singh N. D. P.Chem. Eur. J. 2012, 18, 11968..
[11]
Kulkarni B.A.; Ganesan A. Chem. Commun. 1998, 7, 785.
[12]
Park S.-J.; Lee J.-C.; Lee K.-I. Bull. Korean Chem. Soc. 2007, 28, 1203.
[13]
Fu L.-Q.; Cao X.-J.; Wan J.-P.; Liu Y.-Y. Chin. J. Chem. 2020, 38, 254.
[14]
(a) Xu H.; Zhou B.; Zhou P.; Zhou J.; Shen Y.-H.; Yu F.-C.; Li L.-L. Chem. Commun. 2016, 52, 8002.
[14]
(b) Jiang B.; Yi M.-S.; Shi F.; Tu S.-J.; Pindi S.; McDowell P.; Li G.-G. Chem. Commun. 2012, 48, 808.
[14]
(c) Hu J.-D.; Cao C.-P.; Lin W.; Hu M.-H.; Huang Z.-B.; Shi D.-Q. J. Org. Chem. 2014, 79, 793.
[14]
(d) Hao W.-J.; Wang J.-Q.; Xu X.-P.; Zhang S.-L.; Ji S.-J. J. Org. Chem. 2013, 78, 12362.
[14]
(e) Yu F.-C.; Zhou B.; Xu H.; Chang K.-J.; Shen Y.-H. Tetrahedron Lett. 2015, 56, 837.
[14]
(f) Miao H.-J.; Wang L.-L.; Han H.-B.; Zhao,. Y.-D.; Wang, L.-Q.; Bu, Z.-W.Chem. Sci. 2020, 11, 1418.
[14]
(g) Wang L.-L.; Han H.-B.; Cui Z.-H.; Zhao J.-W.; Bu Z.-W.; Wang Q.-L. Org. Lett. 2020, 22, 873.
[14]
(h) Usman M.; Hu X.-D.; Liu W.-B. Chin. J. Chem. 2020, 38, 737.
[14]
(i) Cao W.-B.; Liu B.-B.; Xu X.-P.; Ji S.-J. Org. Chem. Front. 2018, 5, 1194.
[15]
(a) Makawana J.A.; Patel M.P.; Patel R.G.; Chin. Chem. Lett. 2012, 23, 427.
[15]
(b) Hundsd?rfer C.; Hemmerling H.J.; G?tz C.; Totzke F.; Bednarski P.; Borgne M.L.; Jose J. Bioorg. Med. Chem. 2012, 20, 2282.
[16]
Chen X.-B.; Bai H.-R.; Huang C. Chin. J. Org. Chem. 2017, 37, 881. (in Chinese)
[16]
陈雪冰, 白海瑞, 黄超, 有机化学, 2017, 37, 881.).
[17]
Luo Q.; Huang R.; Xiao Q.; Yao Y.; Lin J.; Yan S.-J. J. Org. Chem. 2019, 84, 1999.
文章导航

/